1 domain / 2 areas / 1 specialization
Negev Capital
Data updated
Negev Capital is a venture capital fund focused on CNS and brain-health therapeutics, with a stated strategy centered on seed to Series A investments. The fund says it is domiciled in the Cayman Islands and that key team members are based in Limassol, Cyprus, Vienna, and New York.
It matters in the psychedelic ecosystem because Negev Capital has backed and exited multiple companies in psychedelic-derived and neuropsychiatric drug development, including Gilgamesh Pharmaceuticals, Mindset Pharma, Bright Minds Biosciences, and others. The fund describes its thesis as supporting psychedelic-derived and novel neuropsychiatric compounds that can mature into mainstream therapeutic categories.
Investor Context
Venture CapitalInvestment Context
This stakeholder is listed as a Venture Capital Fund within Venture Capital. Its public geography context is global. Public stage signals include Seed, Series A/B, and Growth / Late Stage. Public focus areas include Drug Development.
Public Portfolio Examples
- Small Pharma Ltdfollow-on / strategic investment - USD 1 million cumulative - Sep 21, 2021
Negev Capital presents itself as a $30M+ biotech venture fund concentrated on CNS and brain-health therapeutics, with emphasis on early-stage companies and capital-efficient drug development. Its portfolio and realized exits show a strong orientation toward psychedelic-derived and adjacent neuropsychiatric assets, spanning compounds for depression, addiction, epilepsy, and other CNS indications. The firm also operates Negev Labs, a venture studio focused on sourcing and building CNS drug candidates with existing human data.
Investor Type
Venture Capital Fund
Geographic Scope
Global
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Recorded Investments
Sep 21, 2021
follow-on / strategic investment - USD 1 million cumulative
Negev Capital said the investment increased its cumulative exposure to Small Pharma to $1 million.
Negev Capital doubled down on its sizable investment in Small Pharma Inc.Quick Facts
- Founded
- 2021
- HQ
- George Town, Cayman Islands
- Website
- Visit